Jane Street Group LLC Sells 231,839 Shares of The Beauty Health Company (NASDAQ:SKIN)

Jane Street Group LLC cut its holdings in The Beauty Health Company (NASDAQ:SKIN) by 74.1% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 80,832 shares of the company’s stock after selling 231,839 shares during the period. Jane Street Group LLC owned about 0.07% of Beauty Health worth $116,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. Cohen Capital Management Inc. grew its position in shares of Beauty Health by 344.1% in the 3rd quarter. Cohen Capital Management Inc. now owns 572,848 shares of the company’s stock valued at $825,000 after acquiring an additional 443,859 shares during the period. Federated Hermes Inc. raised its stake in Beauty Health by 349,616.0% in the second quarter. Federated Hermes Inc. now owns 370,699 shares of the company’s stock valued at $712,000 after buying an additional 370,593 shares during the period. HighTower Advisors LLC acquired a new stake in shares of Beauty Health in the third quarter valued at approximately $121,000. Bank of New York Mellon Corp boosted its stake in shares of Beauty Health by 24.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 348,108 shares of the company’s stock worth $668,000 after acquiring an additional 69,329 shares during the period. Finally, FMR LLC increased its holdings in shares of Beauty Health by 0.3% during the 3rd quarter. FMR LLC now owns 18,603,037 shares of the company’s stock worth $26,788,000 after acquiring an additional 58,826 shares during the last quarter. Institutional investors own 93.26% of the company’s stock.

Analyst Ratings Changes

Separately, Canaccord Genuity Group lifted their price objective on shares of Beauty Health from $1.25 to $1.75 and gave the stock a “hold” rating in a research report on Wednesday, November 13th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat.com, Beauty Health currently has an average rating of “Hold” and an average price target of $2.55.

Beauty Health Trading Up 0.3 %

Shares of Beauty Health stock opened at $1.52 on Wednesday. The Beauty Health Company has a 52-week low of $0.91 and a 52-week high of $5.17. The stock has a market cap of $188.67 million, a PE ratio of -3.62 and a beta of 0.81. The firm has a 50-day moving average of $1.57 and a 200-day moving average of $1.61. The company has a debt-to-equity ratio of 9.23, a quick ratio of 5.57 and a current ratio of 6.56.

Beauty Health Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.